Deformity of the Forefoot in Children With Unilateral Cerebral Palsy

NCT05662046 | Completed

• 1 other identifier: Mediopied-PC
• Study Type: observational
• Target: 52
• Locations: 1 country
• Sites: 2

Brief Summary

Midfoot and backfoot deformities are well described in children with Cerebral palsy. However, data regarding forefoot deformities in Cerebral palsy remain scarce in a population were foot deformities are the most frequent musculo-skeletal deformities.

Conditions

Forefoot Adductus; Cerebral Palsy

Keywords

Cerebral Palsy; Forefoot Deformity

Outcome Measures

Primary Outcomes (1)

• Measure of the forefoot deformity prevalence in plegia and non-plegia foot during gait in unilateral cerebral palsy children

  we report in our population the forefoot axis measured by the angle between the heel bisector and the axis between the second and third metatarsal.

  1 day

Secondary Outcomes (7)

• Anthropometric factors (age) associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

  1 day

• Anthropometric factors (sexe) associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

  1 day

• Anthropometric factors (type of cerebral palsy)associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

  1 day

• functional factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

  1 day

• biomechanical osteoarticular factors associated with forefoot deformities on plegia side in walking children with unilateral Cerebral Palsy.

  1 day

Eligibility Criteria

• Age: 2 Years - 18 Years
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Probability Sample

Study Population

Walking child with unilateral Cerebral Palsy who benefit of a 3D Motion Analysis on the motion analysis laboratory in Brest, France, between august 2012 and may 2017.

You may qualify if:

• Child who benefit a standardised clinical evaluation before a 3D Gait Analysis with forefoot deformity measure
• Child age less than 18 years old
• Child with left or right unilateral cerebral palsy
• Walking child ( GMFCS score I, II or III)
• In case of several 3D Gait Analysis for the child: the 3D gait analysis was chosen first before any local spasticity treatment with botulinic toxin injection or the 3D gait evaluation the more far from local spastica treatment with botulinic toxin injection was chosen in second .

You may not qualify if:

• Hemiplegia due to another etiology
• History of lower limb or foot surgery before the clinical evaluation
• Local spasticy treatment with botulinic toxin injection less than 3 months before the clinical evaluation
• Participation refusal

Sponsors & Collaborators

• University Hospital, Brest: lead

Study Sites (2)

Houx

Brest, 29609, France

Location

PRIGENT

Concarneau, 29900, France

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, Chronic; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 28, 2019
• First Posted: December 22, 2022
• Study Start: June 14, 2018
• Primary Completion: June 14, 2018
• Study Completion: June 14, 2018
• Last Updated: December 22, 2022

Record last verified: 2022-12

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: Data will be available beginning three years and ending fifteen years following the final study report completion
• Access Criteria: Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.

Locations

FR (2)